AI entity
partnership is the sole category represented across all 1 tracked stories. Canon Medical Systems is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. eyonis LCS appears in 1 tracked AI story from August 4, 2026.
Last mentioned: Aug 4, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
partnership is the sole category represented across all 1 tracked stories. Canon Medical Systems is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. eyonis LCS appears in 1 tracked AI story from August 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering eyonis LCS. Shared-story counts are live from our verified record — not editorial picks.
eyonis LCS becomes the first FDA-cleared AI Software as a Medical Device to assess lung nodule malignancy, and its commercial partnership with Canon’s Olea Medical validates the scale-up of AI diagnostics in radiology.
Source: Globenewswire_fr · Postregister
eyonis LCS is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
